[1]
Pavlovskyi, L. 2018. CERAMIDE AS A MARKER OF SEVERITY AND ACTIVITY OF DIABETES MELLITUS TYPE 2 AND NONALCOHOLIC FATTY LIVER DISEASE. Biological Markers in Fundamental and Clinical Medicine (scientific journal). 2, 2 (Nov. 2018), 68-68. DOI:https://doi.org/10.29256/v.02.02.2018.escbm58.